Showing results (631-640 of 1,651) with videos related to

Sort By:
Pageof 166
Hepatology International|September 28, 2022
A proposal for T1 subclassification in hepatocellular carcinoma: reappraisal of the AJCC 8th editionChao-Wei Lee, Hsin-I Tsai, Ming-Chin Yu, et al.
Hepatology International|January 26, 2021
S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinomaLu-Nan Qi, Liang Ma, Fei-Xiang Wu, et al.
Hepatology International|January 28, 2021
Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shuntJiangqiang Xiao, Jingjing Tu, Han Zhang, et al.
Hepatology International|March 22, 2021
Neonatal hepatitis B vaccination protects mature adults from occult virus infectionRuijun Wang, Chang Liu, Taoyang Chen, et al.
Hepatology International|March 7, 2021
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in TaiwanChen-Hua Liu, Po-Yueh Chen, Jyh-Jou Chen, et al.
Hepatology International|February 3, 2021
Liver injury predicts overall mortality in severe COVID-19: a prospective multicenter study in BrazilFernanda Manhães Pozzobon, Hugo Perazzo, Fernando Augusto Bozza, et al.
Hepatology International|November 25, 2021
Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B studyLung-Yi Mak, Joseph Hoang, Dae Won Jun, et al.
Hepatology International|January 21, 2022
Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver diseaseMaki Morinaga, Kazuyoshi Kon, Akira Uchiyama, et al.
Hepatology International|November 14, 2021
Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trialRakesh Kumar Jagdish, Ahmed Kamaal, Saggere Muralikrishna Shasthry, et al.
Hepatology International|February 27, 2021
High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis BMenghui Duan, Xiaoling Chi, Huanming Xiao, et al.
Pageof 166